AGP Executive Report
Last update: 3 hours agoBrain Science: The 2026 medicine Nobel honors researchers who developed optogenetics, using light-sensitive proteins to control brain cells and study their function. Microplastics: New research offers clues to how tiny plastic particles may trigger inflammation and cell damage. Addiction Research: A $13 million clinical trial will test whether GLP-1 drugs can reduce alcohol and opioid use and improve other outcomes. Earthquake Forecasting: A decade-long test of 27 models found they can describe next-day seismic patterns—but cannot predict the exact time or place of a quake. Cancer Care: AI trained on melanoma tissue slides may predict cancer-driving mutations and help speed treatment decisions; sequencing remains necessary. Viral Testing: A color-changing hepatitis B DNA test delivers results in about an hour using basic equipment, potentially widening access to diagnosis.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
